Patent · US Active

Substituted imidazo[1,2-α]pyrrolo[1,2-d]pyrazines for treating respiratory syncytial virus (RSV) infections

US8604034B2 · kind B2 · utility

0Cited by

22References

18Claims

0Family size

Assignee

BIOTA SCIENTIFIC MANAGEMENT PTY LTD · AU

Inventors

Jeffrey Peter Mitchell · Melbourne, AU
Gary Robert William Pitt · Melbourne, AU
Alistair George Draffan · Melbourne, AU
Penelope Anne Mayes · Melbourne, AU
Laura Andrau · Melbourne, AU
Kelly Helen Anderson · Melbourne, AU

Key dates

Filing date	Feb 8, 2011
Grant date	Dec 10, 2013
Priority date	—
Expiry date	Feb 8, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D405/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds of formula (I)its salts, isomers or prodrugs thereof useful in the treatment of viral infections, in particular respiratory syncytial virus (RSV) infections. The present invention also relates to processes for preparing the compounds and intermediates used in their preparation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.